Long-term Prognosis and Valve Durability of TAVR
Key facts
- Where
- Xi'an, ChinaSee the site
Where in China
- Xijing hospitalXi'an, ChinaContact: Rutao Wang, M.D., Ph.D.Taking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Xijing Hospital
- Trial code
- NCT06379386
- Record updated
- 23 April 2024
- Original description
This registry aims to evaluate the long-term prognosis and valve durability of transcatheter aortic valve replacement (TAVR) in a real-world setting. Baseline characteristics, procedural data, and clinical outcomes will be collected in a prospective and observational manner.Read full original descriptionShow less
Long-term Prognosis and Valve Durability of Transcatheter Aortic Valve Replacement for Aortic Valve Disease: a Real-world, Prospective, Single-center, Observational Study
This registry aims to evaluate the long-term prognosis and valve durability of transcatheter aortic valve replacement (TAVR) in a real-world setting. Baseline characteristics, procedural data, and clinical outcomes will be collected in a prospective and observational manner.
Inclusion: Patients diagnosed with severe aortic valve regurgitation undergo evaluation by the Heart team and are eligible for TAVR therapy; Patients who understand the purpose of this study, agree to participate in the trial and sign the informed consent form; 1. Patients with aortic stenosis or aortic valve insufficiency who were evaluated by the Heart team and underwent TAVR therapy; 2. Patients who understand the purpose of the study, agree to participate in the trial and sign the informed consent form.
Exclusion: 1. Patients who cannot provide informed consent; 2. Patients who are participating in other clinical trials.